News / Health

Malaria Vaccine Shows Acceptable Safety, Efficacy Results

An international health alliance working to develop a vaccine against malaria says one of its most advanced vaccines, called RTS,S, shows promising results.  After two years of human clinical trials in Africa, the PATH Malaria Vaccine Initiative and its collaborators report the vaccine provides protection against malaria for children aged five to 17 months.

Scientists working on the world’s first-ever malaria vaccine are calling the RTS,S trials a significant milestone.

“For 40 years people have been trying to develop malaria vaccine and here we are,” said Dr. Christian Loucq, the director of Malaria Vaccine Initiative, which is an international non-profit group involved in assessing the safety and effectiveness of the new vaccine.  Thousands of children in seven countries in Africa received the vaccine. Investigators found that in vaccinated children, the risk of severe and clinical malaria was reduced by half.

“Phase Three is where you look into efficacy and safety for which we had consistent results and we are very happy and encouraged to move on,” said Dr. Daniel Ansong, a pediatrician and researcher at one of the clinical-trial sites in Ghana.

Dr. Ansong believes the vaccine will be a valuable new weapon in the global war on malaria.

Critics note that in the field trials, the new vaccine was only 47 percent effective against severe malaria, a level of protection they say should be higher. But pediatricians say that with malaria killing 800,000 children every year, even this level of efficacy could save thousands of lives.

Dr. Joe Cohen is co-inventor of the RTS,S vaccine and a researcher at the drug companty GlaxoSmith-line. It has invested $300 million in malaria vaccine development.

Cohen says developing a vaccine against malaria has been a major scientific challenge. “The problem, I think, is the parasite itself. Malaria parasite - parasites in general - very complex organisms, with complex DNA makeup with many thousands of genes, in contrast to bacteria or viruse,” he said.

GlaxoSmith-Kline says it expects to invest an additional $50 to 100 million in the vaccine program.  Researchers say they will start testing the vaccine on larger populations after the successful completion of ongoing Phase Three trials.

The developers plan to submit the final results of the vaccine trials to the World Health Organization by 2014.  Their hope is that the WHO will recommend that the malaria vaccine become a routine part of all future childhood immunization programs.

You May Like

US Imposes Sanctions on Alleged Honduran Drug Gang

Treasury department alleges Los Valles group is responsible for smuggling tens of thousands of kilograms of cocaine into US each month More

At 91, Marvel Creator Stan Lee Continues to Expand his Universe

Company's chief emeritus hopes to interest new generation of children in superheroes of all shapes and sizes by publishing content across multiple media platforms More

Photogallery New Drug Protects Against Virus in Ebola Family

Study by researchers at University of Texas Medical Branch, Tekmira Pharmaceuticals is first looking at drug's effectiveness after onset of symptoms More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
African Media Tries to Educate Public About Ebolai
X
George Putic
August 20, 2014 8:57 PM
While the Ebola epidemic continues to claim lives in West Africa, information technology specialists, together with radio and TV reporters, are battling misinformation and prejudice about the disease - using social media to educate the public about the deadly virus. VOA’s George Putic has more.
Video

Video African Media Tries to Educate Public About Ebola

While the Ebola epidemic continues to claim lives in West Africa, information technology specialists, together with radio and TV reporters, are battling misinformation and prejudice about the disease - using social media to educate the public about the deadly virus. VOA’s George Putic has more.
Video

Video Ferguson Calls For Justice as Anger, Violence Grips Community

Violence, anger and frustration continue to grip the small St. Louis suburb of Ferguson, Missouri. Protests broke out after a white police officer fatally shot an unarmed black teenager on August 9. The case has sparked outrage around the nation and prompted the White House to send U.S. Attorney Eric Holder to the small community of just over 20,000 people. VOA’s Mary Alice Salinas has more from Ferguson.
Video

Video Beheading Of US Journalist Breeds Outrage

U.S. and British authorities have launched an investigation into an Islamic State video showing the beheading of kidnapped American journalist James Foley by a militant with a British accent. The extremist group, which posted the video on the Internet Tuesday, said the murder was revenge for U.S. airstrikes on militant positions in Iraq - and has threatened to execute another American journalist it is holding. Henry Ridgwell has more from London.
Video

Video Family Robots - The Next Big Thing?

Robots that can help us with daily chores like cooking and cleaning are a long way off, but automatons that serve as family companions may be much closer. Researchers in the United States, France, Japan and other countries are racing to build robots that can entertain and perform some simpler tasks for us. VOA’s George Putic reports.
Video

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As the Ukrainian military reclaims control of eastern cities from pro-Russian separatists, residents are getting a chance to rebuild their lives. VOA's Gabe Joselow reports from the town of Kramatorsk in Donetsk province, where a sense of fear is still in the air, and distrust of the government in Kyiv still runs deep.
Video

Video Five Patients Given Experimental Ebola Drug Said to Be Improving

The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video China Targets Overseas Assets of Corrupt Officials

As China presses forward with its anti-graft effort, authorities are targeting corrupt officials who have sent family members and assets overseas. The efforts have stirred up a debate at home on exactly how many officials take that route and how likely it is they will be caught. Rebecca Valli has this report.
Video

Video Leading The Fight Against Islamic State, Kurds Question Iraqi Future

Western countries including the United States have begun arming the Kurdish Peshmerga forces in northern Iraq to aid their battle against extremist Sunni militants from the Islamic State. But there are concerns that a heavily-armed Kurdistan Regional Government, or KRG, might seek to declare independence and cause the break-up of the Iraqi state. As Henry Ridgwell reports from London, the KRG says it will only seek greater autonomy from Baghdad.
Video

Video In Rural Kenya, Pressure Builds Against Female Circumcision

In some Kenyan communities, female genital mutilation remains a rite of passage. But activists are pushing back, with education for girls and with threats of punishment those who perform the circumcision. Mohammed Yusuf looks at the practice in the rural eastern community of Tharaka-Nithi.

AppleAndroid